Vyant Bio, Inc. Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Warrants - Summary of Derivative Warrant Activity (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Class of Warrants Outstanding [Roll Forward]
Beginning balance			$ 594,000
Fair value of warrants exercised			(125,000)
Change in fair value of warrant liability	(129,000)	1,033,000	(324,000)	(4,096,000)
Ending balance	145,000		145,000
Debt Guarantee [Member]
Class of Warrants Outstanding [Roll Forward]
Beginning balance			64,000
Fair value of warrants exercised			(87,000)
Change in fair value of warrant liability			23,000
Ending balance	0		0
Consulting [Member]
Class of Warrants Outstanding [Roll Forward]
Beginning balance			1,000
Fair value of warrants exercised			0
Change in fair value of warrant liability			0
Ending balance	1,000		1,000
Financing [Member]
Class of Warrants Outstanding [Roll Forward]
Beginning balance			412,000
Fair value of warrants exercised			0
Change in fair value of warrant liability			(293,000)
Ending balance	119,000		119,000
Series B Preferred Stock [Member]
Class of Warrants Outstanding [Roll Forward]
Beginning balance			117,000
Fair value of warrants exercised			(38,000)
Change in fair value of warrant liability			(54,000)
Ending balance	$ 25,000		$ 25,000